BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 4
• 5
• 6
• 7
• 8
• 10
• 11
• 12
• 13
• 14
• 15
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27

• Business

  Arena Pharmaceuticals, Inc. Expands Deal With Eisai Inc. on Sales of Obesity Drug

  November 8, 2013

   · 

  1 min read
• Business

  TrovaGene, Inc. Schedules Release of Third Quarter 2013 Financial Results and Hosts Investor Conference Call

  November 8, 2013

   · 

  1 min read
• FDA

  Hong Kong Authority Approves Mundipharma AG’s Flutiform® (fluticasone propionate/formoterol fumarate), a New Treatment for Asthma

  November 8, 2013

   · 

  7 min read
• Biotech Bay

  Auxogyn, Inc. CEO to Participate in Panel at New York CEO Conference

  November 8, 2013

   · 

  2 min read
• Business

  Emergent BioSolutions Reports Financial Results for Third Quarter and First Nine Months of 2013

  November 8, 2013

   · 

  1 min read
• Lone Star Bio

  Data from Bio-Path Holdings, Inc. Phase I Clinical Trial in Hematological Cancers to be Presented at American Society of Hematology Annual Meeting

  November 8, 2013

   · 

  1 min read
• Business

  XenoPort, Inc. Reports Third Quarter Financial Results

  November 8, 2013

   · 

  1 min read
• Mallinckrodt Pharmaceuticals to Hold Investor Briefing in New York

  November 8, 2013

   · 

  1 min read
• BioMidwest

  ProNAi Therapeutics, Inc. to Present Phase II Clinical Data at American Society of Hematology for PNT2258, a BCL2 Targeted Drug

  November 8, 2013

   · 

  1 min read
• Biotech Beach

  Santarus Inc. and Pharming Group Announce New Data From Open-Label Repeat Treatment Study With RUCONEST (Recombinant Human C1 Esterase Inhibitor)

  November 8, 2013

   · 

  1 min read